CR8, a novel inhibitor of CDK, limits microglial activation, astrocytosis, neuronal loss, and neurologic dysfunction after experimental traumatic brain injury.
Kabadi SV, Stoica BA, Loane DJ, Luo T, Faden AI. J Cereb Blood Flow Metab. 2014 Mar; 34(3):502-13. Epub 2014 Jan 8.